ASCO Names Refinement of Surgical Treatment of Cancer as Advance of the Year

14:02 EST 4 Feb 2020 | OncLive

Following significant progress made in the development of novel systemic therapies for patients with cancer, the role of surgery in oncology continues to evolve. To this end, ASCO has selected the refinement of surgical treatment of cancer as its Advance of the Year.

More From BioPortfolio on "ASCO Names Refinement of Surgical Treatment of Cancer as Advance of the Year"